MoneyWorks4Me

Norris Medicines informs about compliance certificate

05 Apr 2022 Evaluate
Norris Medicines has informed that it enclosed a certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the period 01st January, 2022 to 31st March, 2022, received from PurvaSharegistry (I), Registrar and Share Transfer Agent of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..